Hour24 News
Sophisticated and simple
-
Overview: A new path for ADA-SCID treatment Researchers from UCLA, University College London, and Great Ormond Street Hospital have reported a remarkable milestone in the…
-
Canada launches Sogroya: a pioneering once-weekly growth hormone treatment Canada has officially announced the commercialization of Sogroya® (somapacitan injection), marking a significant advancement in the…
-
Overview: a paradox in the global drug problem Recent analyses based on the Global Burden of Disease (GBD) 2021 data reveal a striking paradox: while…
-
Rising hopes and a difficult turn Emma McDonald, a 38-year-old British mother, turned to Mounjaro (tirzepatide) in mid-2024 after years of struggling to lose weight…
-
Loneliness and cancer: a growing public health concern Loneliness and social isolation are more than emotional states; when they persist, they may influence health outcomes…
-
New laser at MCH protects vision for premature babies Hamilton Health Sciences’ McMaster Children’s Hospital (MCH) has taken a major step forward in safeguarding the…
-
New Irish findings connect lifetime oestrogen exposure and dementia risk A new study from Ireland suggests that women who maintain higher exposure to oestrogen across…
-
Overview: A Historic View of MDMA in Psychotherapy The October 2025 issue of Psychedelics offers a comprehensive review of MDMA-assisted psychotherapy, tracing its journey from…
-
Can a cholesterol drug really help fight prostate cancer? A new study suggests that cholesterol-lowering statins might do more than manage cholesterol levels. When used…
-
Can a cholesterol drug really help fight advanced prostate cancer? New research suggests that cholesterol-lowering statins could play a role in extending the lives of…
